ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Bruker Introduces Dimension Nexus™ Atomic Force Microscope

Upgradable Large-Sample System Sets New Performance Standard for Cost-Effective AFMs

At the 2024 MRS Fall Meeting & Exhibit, Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Dimension Nexus™ atomic force microscope (AFM). Dimension Nexus is the newest addition to the industry-leading Dimension® AFM product line, which has had more than 4600 systems installed around the world. With the latest-generation NanoScope® 6 controller, this new small-footprint AFM delivers wider access to Bruker’s exclusive PeakForce Tapping® technology and over 50 AFM modes. The upgradability and enhanced ease of use of Dimension Nexus provides an optimal intersection of performance and value for the evolving needs of both growing labs and multi-user facilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241202516581/en/

The Dimension Nexus atomic force microscope (right) with the latest-generation NanoScope 6 controller (left) (Photo: Business Wire)

The Dimension Nexus atomic force microscope (right) with the latest-generation NanoScope 6 controller (left) (Photo: Business Wire)

“We already have a number of Bruker AFMs in our open-access user facilities and are always looking for new technology that can further support the many researchers we serve from both academia and industry,” said Dr. Alice Pyne, Head of the Henry Royce Nanocharacterisation Laboratory at the University of Sheffield. “I especially appreciate the compact and upgradable nature of the Dimension Nexus large-sample AFM, and the fact that it can perform the latest PeakForce Tapping modes. I can see this being a real advantage for multi-user labs, where AFM expertise and applications vary, and where physical space for instruments is at a premium.”

“With the release of Nexus, we have taken a significant step in making the very latest AFM technology available to a wider research community,” added Thomas Mueller, Senior Director of AFM Instrumentation at Bruker. “Its combination of data quality, performance, and versatility make it both an excellent starter AFM and a perfect addition to a thriving AFM lab.”

About Dimension Nexus

Taking advantage of decades of AFM innovation, Dimension Nexus delivers exceptional value. Its open-architecture system with low drift and low noise enables researchers to collect high-quality data for both routine and custom experiments. The high-speed NanoScope 6 controller, combined with Bruker’s exclusive ScanAsyst® technology, ensures unprecedented ease of use. This small-footprint, versatile system boosts productivity with a programmable stage for high-throughput multi-site analysis. Additionally, Dimension Nexus supports a wide array of unique modes, such as AFM-nDMA for viscoelastic measurements, PeakForce QNM® for high-resolution quantitative mapping of mechanical properties, and DataCube modes for hyperspectral imaging.

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.